# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-25-000600
Filing Date
2025-09-19
Accepted
2025-09-19 07:01:32
Documents
6

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS | tech014339-defa14a.htm | DEFA14A | 9296
2 | GRAPHIC | check01.jpg | GRAPHIC | 1195
3 | GRAPHIC | uncheck.jpg | GRAPHIC | 1002
4 | GRAPHIC | logo.jpg | GRAPHIC | 36712
5 | GRAPHIC | ltech_proxy1.jpg | GRAPHIC | 2241722
6 | GRAPHIC | ltech_proxy2.jpg | GRAPHIC | 1329462
| Complete submission text file | 0001308179-25-000600.txt |  | 4982010

Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E SUITE 1500 MINNEAPOLIS MN 55413 612-379-8854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

EIN.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 000-17272 | Film No.: 251324916
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)